Cynata already has results from two human studies with three ongoing and due to readout within 16 months. Seriously, you have a problem, I think it's time you paid a visit to AA.
- Forums
- ASX - By Stock
- CYP Price Target post MSB FDA approval.
CYP
cynata therapeutics limited
Add to My Watchlist
3.03%
!
16.0¢

Cynata already has results from two human studies with three...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.0¢ | $58.52K | 355.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 613829 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 14285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 999 | 0.165 |
6 | 807381 | 0.160 |
3 | 26451 | 0.155 |
2 | 55000 | 0.150 |
3 | 48937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 1000 | 1 |
0.165 | 39998 | 1 |
0.175 | 14285 | 1 |
0.180 | 108714 | 5 |
0.185 | 142506 | 4 |
Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online